Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             30 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Advances in molecular glues: exploring chemical space and design principles for targeted protein degradation Hemant Kumar, S

29 11 p.
artikel
2 Application of proteomics for novel drug discovery and risk prediction optimisation in stroke and myocardial infarction: a review of in-human studies Webb, Richard J.

29 11 p.
artikel
3 Beyond resmetirom approval for NAFLD: what has to be done? Ezhilarasan, Devaraj

29 11 p.
artikel
4 Clinical strategies with antibody–drug conjugates as potential modifications for virotherapy Liao, Zi-Xian

29 11 p.
artikel
5 Collaborative GSK–University of Strathclyde doctoral research and training programmes: Transforming approaches to industry–academia engagement Paterson, Laura C.

29 11 p.
artikel
6 Contents page
29 11 p.
artikel
7 Data-driven toxicity prediction in drug discovery: Current status and future directions Wang, Ningning

29 11 p.
artikel
8 Design of bifunctional molecules to accelerate post-translational modifications: achievements and challenges Wang, Yuxuan

29 11 p.
artikel
9 3D light-sheet fluorescence microscopy in preclinical and clinical drug discovery Roostalu, Urmas

29 11 p.
artikel
10 Downregulation of microRNA-29b in cancer and fibrosis: molecular insights and clinical implications Shinde, Pratik Pramod

29 11 p.
artikel
11 Drug discovery and development in idiopathic pulmonary fibrosis: the changing landscape Cruwys, Simon

29 11 p.
artikel
12 Early career researchers’ experiences in drug discovery in Africa Mayoka, Godfrey

29 11 p.
artikel
13 Embryonic and larval zebrafish models for the discovery of new bioactive compounds against tuberculosis Antunes, Stella S.

29 11 p.
artikel
14 Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment Hu, Lingrong

29 11 p.
artikel
15 From promise to progress: the dynamic landscape of glioblastoma immunotherapy Ijaz, Muhammad

29 11 p.
artikel
16 Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections Bhat, Mohammad Faizan

29 11 p.
artikel
17 MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer Pulous, Fadi E.

29 11 p.
artikel
18 MicroRNAs and therapeutic potentials in acute and chronic cardiac disease Song, Rui

29 11 p.
artikel
19 Neurotrophin peptidomimetics for the treatment of neurodegenerative diseases Madhubala, Dev

29 11 p.
artikel
20 P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators Guo, Yang

29 11 p.
artikel
21 Promising therapeutic targets for tumor treatment: Cleaved activation of receptors in the nucleus Fu, Mengdie

29 11 p.
artikel
22 Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches de Jong, Amos J.

29 11 p.
artikel
23 Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery Maani, Zahra

29 11 p.
artikel
24 Targeted protein degradation: current molecular targets, localization, and strategies Pliatsika, Dimanthi

29 11 p.
artikel
25 The pharmaceutical productivity gap – Incremental decline in R&D efficiency despite transient improvements Fernald, Kenneth D.S.

29 11 p.
artikel
26 The regulatory mechanism of natural polysaccharides in type 2 diabetes mellitus treatment Bo, Surina

29 11 p.
artikel
27 Unveiling the macrophage dynamics in osteoarthritic joints: From inflammation to therapeutic strategies Gaigeard, Nicolas

29 11 p.
artikel
28 Unveiling the potential of molecular imprinting polymer-based composites in the discovery of advanced drug delivery carriers Kumar, Amit

29 11 p.
artikel
29 Utilization of phase I studies for target validation of first-in-class drugs Kawabe, Yoshiki

29 11 p.
artikel
30 Which cryptic sites are feasible drug targets? Lazou, Maria

29 11 p.
artikel
                             30 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland